INNMF
Price
$0.12
Change
-$0.01 (-7.69%)
Updated
Sep 5 closing price
Capitalization
52.04M
IPHYF
Price
$2.06
Change
+$0.75 (+57.25%)
Updated
Aug 11 closing price
Capitalization
197.73M
Interact to see
Advertisement

INNMF vs IPHYF

Header iconINNMF vs IPHYF Comparison
Open Charts INNMF vs IPHYFBanner chart's image
Amplia Therapeutics
Price$0.12
Change-$0.01 (-7.69%)
Volume$1.4K
Capitalization52.04M
Innate Pharma
Price$2.06
Change+$0.75 (+57.25%)
Volume$300
Capitalization197.73M
INNMF vs IPHYF Comparison Chart in %
Loading...
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INNMF vs. IPHYF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INNMF is a Hold and IPHYF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (INNMF: $0.12 vs. IPHYF: $2.06)
Brand notoriety: INNMF and IPHYF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INNMF: 2% vs. IPHYF: 79%
Market capitalization -- INNMF: $52.04M vs. IPHYF: $197.73M
INNMF [@Biotechnology] is valued at $52.04M. IPHYF’s [@Biotechnology] market capitalization is $197.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INNMF’s FA Score shows that 0 FA rating(s) are green whileIPHYF’s FA Score has 0 green FA rating(s).

  • INNMF’s FA Score: 0 green, 5 red.
  • IPHYF’s FA Score: 0 green, 5 red.
According to our system of comparison, INNMF is a better buy in the long-term than IPHYF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INNMF’s TA Score shows that 4 TA indicator(s) are bullish while IPHYF’s TA Score has 3 bullish TA indicator(s).

  • INNMF’s TA Score: 4 bullish, 4 bearish.
  • IPHYF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both INNMF and IPHYF are a good buy in the short-term.

Price Growth

INNMF (@Biotechnology) experienced а +4.66% price change this week, while IPHYF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHYF($198M) has a higher market cap than INNMF($52M). INNMF YTD gains are higher at: 199.031 vs. IPHYF (-28.983).
INNMFIPHYFINNMF / IPHYF
Capitalization52M198M26%
EBITDA-6.43MN/A-
Gain YTD199.031-28.983-687%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash10.9MN/A-
Total Debt13.9KN/A-
FUNDAMENTALS RATINGS
INNMF vs IPHYF: Fundamental Ratings
INNMF
IPHYF
OUTLOOK RATING
1..100
5441
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
89100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
3539
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INNMF's Valuation (41) in the null industry is somewhat better than the same rating for IPHYF (75). This means that INNMF’s stock grew somewhat faster than IPHYF’s over the last 12 months.

INNMF's Profit vs Risk Rating (89) in the null industry is in the same range as IPHYF (100). This means that INNMF’s stock grew similarly to IPHYF’s over the last 12 months.

IPHYF's SMR Rating (95) in the null industry is in the same range as INNMF (97). This means that IPHYF’s stock grew similarly to INNMF’s over the last 12 months.

INNMF's Price Growth Rating (35) in the null industry is in the same range as IPHYF (39). This means that INNMF’s stock grew similarly to IPHYF’s over the last 12 months.

INNMF's P/E Growth Rating (100) in the null industry is in the same range as IPHYF (100). This means that INNMF’s stock grew similarly to IPHYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INNMFIPHYF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
55%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
59%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
56%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
47%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
40%
Advances
ODDS (%)
Bullish Trend 3 days ago
65%
N/A
Declines
ODDS (%)
Bearish Trend 15 days ago
66%
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
INNMF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CKHGY97.311.01
+1.05%
Capitec Bank Holdings Ltd
KLBAY7.01N/A
N/A
Klabin S.A.
SPCO0.84N/A
N/A
The Stephan Co.
MXLLF12.76N/A
N/A
MAXELL LTD.
PVBK10.70N/A
N/A
Pacific Valley Bancorp

INNMF and

Correlation & Price change

A.I.dvisor tells us that INNMF and BIVI have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INNMF and BIVI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INNMF
1D Price
Change %
INNMF100%
-3.21%
BIVI - INNMF
26%
Poorly correlated
+9.43%
HOFBF - INNMF
23%
Poorly correlated
N/A
CYTK - INNMF
23%
Poorly correlated
+6.55%
PHRRF - INNMF
20%
Poorly correlated
-0.07%
IVEVF - INNMF
15%
Poorly correlated
N/A
More

IPHYF and

Correlation & Price change

A.I.dvisor tells us that IPHYF and KNBIF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPHYF and KNBIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
KNBIF - IPHYF
6%
Poorly correlated
N/A
INNMF - IPHYF
6%
Poorly correlated
-3.21%
OTLC - IPHYF
4%
Poorly correlated
+10.06%
ISCO - IPHYF
1%
Poorly correlated
N/A
LIXT - IPHYF
1%
Poorly correlated
+2.24%
More